Assignee
CELLESTIA BIOTECH AG
CH·2 granted patents·6 pending applications·2 citations·filing 2019–2022
Top patents by PatentIndex Score
8 records- 0182US11472771B2Process for making amino diaryl ethers and amino diaryl ethers hydrochloride saltsCELLESTIA BIOTECH AG·Filed 2019·Granted Oct 18, 2022·2 cites·22 claims
- 0270US12030855B2Process for making amino diaryl ethers and amino diaryl ethers hydrochloride saltsCELLESTIA BIOTECH AG·Filed 2022·Granted Jul 9, 2024·0 cites·22 claims
- 0354US2025000870A1Pharmaceutical Combinations for Treating CancerCELLESTIA BIOTECH AG·Filed 2022·Application pending·0 cites
- 0450US2024269120A1Method for Treating an Autoimmune and Inflammatory DiseaseCELLESTIA BIOTECH AG·Filed 2022·Application pending·0 cites
- 0550US2024041884A1Pharmaceutical Combinations for Treating CancerCELLESTIA BIOTECH AG·Filed 2021·Application pending·0 cites
- 0646US2023338347A1New Use of Inhibitors of the Notch Signalling PathwayCELLESTIA BIOTECH AG·Filed 2021·Application pending·0 cites
- 0745US2022185793A1Compounds for the treatment of oncovirus induced cancer and methods of use thereofCELLESTIA BIOTECH AG·Filed 2020·Application pending·0 cites
- 0844US2022169642A1Compounds for the treatment of oncovirus induced cancer and methods of use thereofCELLESTIA BIOTECH AG·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CELLESTIA BIOTECH AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →